Financial Strategies Group’s Tenet Healthcare THC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$910K Buy
4,631
+393
+9% +$72.3K 0.15% 62
2026
Q1
$786K Buy
4,238
+308
+8% +$64.9K 0.13% 65
2025
Q4
$818K Buy
3,930
+279
+8% +$56.4K 0.15% 61
2025
Q3
$735K Sell
3,651
-302
-8% -$53.6K 0.14% 62
2025
Q2
$695K Sell
3,953
-458
-10% -$68.9K 0.14% 64
2025
Q1
$533K Buy
4,411
+1,047
+31% +$138K 0.13% 67
2024
Q4
$431K Buy
3,364
+929
+38% +$138K 0.1% 72
2024
Q3
$378K Buy
2,435
+144
+6% +$21.8K 0.09% 74
2024
Q2
$300K Buy
+2,291
New +$276K 0.08% 76

Other funds holding THC

Financial Strategies Group's THC Position: Q2 2026 in Review

Financial Strategies Group increased its Tenet Healthcare (THC) stake by 9.3% in Q2 2026, buying an estimated $72.3K and bringing the position to 4,631 shares worth $910K. The position accounts for 0.15% of the portfolio, ranked #62.

Financial Strategies Group first reported a position in THC in Q2 2024 and has held it in 9 quarters since. 681 funds tracked by Wall St. Rank hold THC as of Q2 2026.

  • Financial Strategies Group held 4,631 shares of Tenet Healthcare worth $910K as of Q2 2026.
  • Financial Strategies Group bought 393 Tenet Healthcare shares in Q2 2026, an estimated $72.3K.
  • Tenet Healthcare made up 0.15% of Financial Strategies Group's portfolio in Q2 2026, its #62 holding.
  • Financial Strategies Group first reported a position in Tenet Healthcare in Q2 2024 and has held it in 9 quarters since.
  • 681 funds tracked by Wall St. Rank held Tenet Healthcare as of Q2 2026.

Based on Financial Strategies Group's 13F filing for Q2 2026, filed 11 Aug 2026.